Cohort building: real-world applications from AstraZeneca & Boehringer Ingelheim

Clinical trials generate vast amounts of valuable data, including bio-samples, imaging results, and reports of adverse events. Efficiently reusing these assets can accelerate research while reducing risks and costs. However, challenges such as data fragmentation and limited access often complicate these efforts.

In this webinar, experts from AstraZeneca and Boehringer Ingelheim will discuss how they (will) utilize the DISQOVER platform to build cohorts, enhancing the accessibility and usability of clinical trial data. Learn how DISQOVER's intuitive knowledge discovery platform allows researchers to quickly integrate, explore, and utilize clinical trial data—without requiring advanced data science expertise.